|
1
|
Kolodziej A, Krajewski W, Matuszewski M
and Tupikowski K: Review of current optical diagnostic techniques
for non-muscle-invasive bladder cancer. Cent European J Urol.
69:150–156. 2016.PubMed/NCBI
|
|
2
|
D'Costa JJ, Goldsmith JC, Wilson JS, Bryan
RT and Ward DG: A systematic review of the diagnostic and
prognostic value of urinary protein biomarkers in urothelial
bladder cancer. Bladder Cancer. 2:301–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistic, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Madka V, Mohammed A, Li Q, Zhang Y,
Biddick L, Patlolla JM, Lightfoot S, Towner RA, Wu XR, Steele VE,
et al: Targeting mTOR and p53 signaling inhibits muscle invasive
bladder cancer in vivo. Cancer Prev Res (Phila). 9:53–62. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Metalli D, Lovat F, Tripodi F, Genua M, Xu
SQ, Spinelli M, Alberghina L, Vanoni M, Baffa R, Gomella LG, et al:
The insulin-like growth factor receptor I promotes motility and
invasion of bladder cancer cells through Akt- and mitogen-activated
protein kinase-dependent activation of paxillin. Am J Pathol.
176:2997–3006. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Muto S, Horie S, Takahashi S, Tomita K and
Kitamura T: Genetic and epigenetic alterations in normal bladder
epithelium in patients with metachronous bladder cancer. Cancer
Res. 60:4021–4025. 2000.PubMed/NCBI
|
|
8
|
van Kessel KE, Van Neste L, Lurkin I,
Zwarthoff EC and Van Criekinge W: Evaluation of an epigenetic
profile for the detection of bladder cancer in patients with
hematuria. J Urol. 195:601–607. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen M, Ye Y, Zou B, Guo S, Zhou F, Lu K,
Liu J, Xu Z, Han H, Liu Z, et al: C14orf166 is a high-risk
biomarker for bladder cancer and promotes bladder cancer cell
proliferation. J Transl Med. 14:552016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hata A and Kashima R: Dysregulation of
microRNA biogenesis machinery in cancer. Crit Rev Biochem Mol Biol.
51:121–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tani H, Imamachi N, Mizutani R, Imamura K,
Kwon Y, Miyazaki S, Maekawa S, Suzuki Y and Akimitsu N: Genome-wide
analysis of long noncoding RNA turnover. Methods Mol Biol.
1262:305–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kit OI, Kirichenko EY, Kirichenko YG,
Novikova IA, Selyutina ON and Filippova SY: The long non-coding RNA
associated with cancerogenesis: biological significance and
perspectives of application in diagnostic. Klin Lab Diagn.
61:13–16. 2016.PubMed/NCBI
|
|
13
|
Liu Q, Zhang X, Dai L, Hu X, Zhu J, Li L,
Zhou C and Ao Y: Long noncoding RNA related to cartilage injury
promotes chondrocyte extracellular matrix degradation in
osteoarthritis. Arthritis Rheumatol. 66:969–978. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng N, Wang Y, Zheng M, Yu X, Lin H, Ma
RN, Shi O, Zheng X, Gao M, Yu H, et al: Genome-wide analysis of DNA
methylation and their associations with long noncoding RNA/mRNA
expression in non-small-cell lung cancer. Epigenomics. 2017.(Epub
ahead of print). View Article : Google Scholar
|
|
16
|
Deng H, Zhang J, Shi J, Guo Z, He C, Ding
L, Tang JH and Hou Y: Role of long non-coding RNA in tumor drug
resistance. Tumour Biol. 37:11623–11631. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Flippot R, Malouf GG, Su X, Mouawad R,
Spano JP and Khayat D: Cancer subtypes classification using long
non-coding RNA. Oncotarget. 7:54082–54093. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liao T, Qu N, Shi RL, Guo K, Ma B, Cao YM,
Xiang J, Lu ZW, Zhu YX, Li DS and Ji QH: BRAF-activated LncRNA
functions as a tumor suppressor in papillary thyroid cancer.
Oncotarget. 8:238–247. 2017.PubMed/NCBI
|
|
19
|
Dong Y, Huo X, Sun R, Liu Z, Huang M and
Yang S: LncRNA Gm15290 promotes cell proliferation and invasion in
non-small cell lung cancer through directly interacting with and
suppressing the tumor suppressor miR-615-5p. Oncol Res. 2017.(Epub
ahead of print). View Article : Google Scholar
|
|
20
|
Hua Q, Lv X, Gu X, Chen Y, Chu H, Du M,
Gong W, Wang M and Zhang Z: Genetic variants in lncRNA H19 are
associated with the risk of bladder cancer in a Chinese population.
Mutagenesis. 31:531–538. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen P, Wan D, Zheng D, Zheng Q, Wu F and
Zhi Q: Long non-coding RNA UCA1 promotes the tumorigenesis in
pancreatic cancer. Biomed Pharmacother. 83:1220–1226. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen M, Li J, Zhuang C and Cai Z:
Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of
bladder cancer. Oncotarget. 8:28176–28186. 2017.PubMed/NCBI
|
|
23
|
Pei Z, Du X, Song Y, Fan L, Li F, Gao Y,
Wu R, Chen Y, Li W, Zhou H, et al: Down-regulation of lncRNA CASC2
promotes cell proliferation and metastasis of bladder cancer by
activation of the Wnt/β-catenin signaling pathway. Oncotarget.
8:18145–18153. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tam OH, Aravin AA, Stein P, Girard A,
Murchison EP, Cheloufi S, Hodges E, Anger M, Sachidanandam R,
Schultz RM and Hannon GJ: Pseudogene-derived small interfering RNAs
regulate gene expression in mouse oocytes. Nature. 453:534–538.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Watanabe T, Totoki Y, Toyoda A, Kaneda M,
Kuramochi-Miyagawa S, Obata Y, Chiba H, Kohara Y, Kono T, Nakano T,
et al: Endogenous siRNAs from naturally formed dsRNAs regulate
transcripts in mouse oocytes. Nature. 453:539–543. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Haudenschild DR, Chen J, Pang N, Steklov
N, Grogan SP, Lotz MK and D'Lima DD: Vimentin contributes to
changes in chondrocyte stiffness in osteoarthritis. J Orthop Res.
29:20–25. 2011. View Article : Google Scholar : PubMed/NCBI
|
